Oriola Oyj (FRA:O5O)

Germany flag Germany · Delayed Price · Currency is EUR
1.096
-0.006 (-0.54%)
At close: Dec 4, 2025
22.32%
Market Cap 204.88M
Revenue (ttm) 1.85B
Net Income (ttm) -27.10M
Shares Out n/a
EPS (ttm) -0.15
PE Ratio n/a
Forward PE 11.13
Dividend 0.07 (6.42%)
Ex-Dividend Date Apr 3, 2025
Volume n/a
Average Volume n/a
Open 1.096
Previous Close 1.102
Day's Range 1.096 - 1.096
52-Week Range 0.877 - 1.202
Beta n/a
RSI 44.28
Earnings Date Feb 25, 2026

About Oriola Oyj

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company also distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tend... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries
Founded 1907
Employees 934
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol O5O
Full Company Profile

Financial Performance

In 2024, Oriola Oyj's revenue was 1.68 billion, an increase of 12.45% compared to the previous year's 1.50 billion. Losses were -20.10 million, -2.90% less than in 2023.

Financial Statements

News

There is no news available yet.